Search clinical trials for: chemo-care (CC) 5013- Revlimid
Total 6920 results
-
CelgeneCompletedMyelodysplastic SyndromeUnited States
-
Celgene CorporationCompletedMyelodysplastic SyndromesUnited States, Denmark, Australia, Belgium, Czech Republic, France, Germany, Greece, Italy, Netherlands, Russian Federation, Spain, Sweden, Switzerland, United Kingdom
-
CelgeneCompletedMyelodysplastic SyndromesUnited States, Germany
-
Celgene CorporationPrologue Research InternationalTerminatedPancreatic CancerUnited States
-
M.D. Anderson Cancer CenterCelgene CorporationCompleted
-
Memorial Sloan Kettering Cancer CenterActive, not recruiting
-
Celgene CorporationPrologue Research InternationalCompletedOvarian CancerUnited States
-
University of ArkansasCompletedMultiple MyelomaUnited States
-
Celgene CorporationPrologue Research InternationalTerminated
-
Dana-Farber Cancer InstituteBeth Israel Deaconess Medical Center; Genentech, Inc.; Brigham and Women's Hospital and other collaboratorsTerminatedWaldenstrom's MacroglobulinemiaUnited States
-
CelgeneCompletedMultiple MyelomaUkraine, Russian Federation
-
Memorial Sloan Kettering Cancer CenterWeill Medical College of Cornell University; Celgene Corporation; University... and other collaboratorsCompletedMultiple Myeloma | Non-Hodgkin's LymphomaUnited States
-
Memorial Sloan Kettering Cancer CenterColumbia University; Montefiore Medical Center; Weill Medical College of Cornell... and other collaboratorsCompleted
-
M.D. Anderson Cancer CenterCelgene CorporationCompleted
-
Celgene CorporationPrologue Research InternationalCompletedNon-Hodgkins LymphomaUnited States
-
Celgene CorporationPrologue Research InternationalCompletedNon-Hodgkins LymphomaUnited States, Canada
-
National Cancer Institute (NCI)CompletedBrain and Central Nervous System TumorsUnited States
-
CelgeneCompletedMultiple MyelomaSpain, United Kingdom, Switzerland, Australia, Israel, Italy, Poland, France, Belgium, Ireland, Austria, Germany, Ukraine, Greece, Sweden
-
Dana-Farber Cancer InstituteBeth Israel Deaconess Medical Center; Brigham and Women's Hospital; H. Lee Moffitt...CompletedMultiple Myeloma | Refractory Multiple Myeloma | Relapsed Multiple MyelomaUnited States
-
CelgeneCompletedLymphoma, Non-Hodgkin'sUnited States, Spain, Germany, France, Italy, Canada, United Kingdom
-
Celgene CorporationCompletedMultiple MyelomaUnited States
-
Celgene CorporationCompletedRelapsed or Refractory Multiple MyelomaGermany
-
Celgene CorporationPrologue Research InternationalTerminated
-
CelgeneCompletedMantle Cell LymphomaUnited States, France, Belgium, Austria, Israel, Singapore, Spain, United Kingdom, Hungary, Colombia, Germany, Italy, Turkey, Puerto Rico
-
University of Turin, ItalyCompletedMultiple MyelomaItaly
-
Celgene CorporationCompletedMultiple MyelomaUnited States
-
CelgeneTerminatedNon-Hodgkin's Lymphoma | Mantle Cell LymphomaUnited States, Spain, United Kingdom, Germany, France, Czechia, Israel, Italy, Poland, Portugal, Puerto Rico, Russian Federation
-
Celgene CorporationPrologue Research InternationalCompletedNon-Small Cell Lung CancerUnited States
-
Celgene CorporationCompletedRadiculopathyUnited States
-
Mayo ClinicCompletedAmyloidosisUnited States
-
Vaishali SanchorawalaCelgene CorporationCompletedMultiple MyelomaUnited States
-
CelgeneCompletedMultiple MyelomaUnited States, Canada
-
CelgenePrologue Research InternationalCompleted
-
Celgene CorporationCompletedComplex Regional Pain Syndrome (RSD)United States
-
University of WuerzburgCompletedRefractory Multiple Myeloma | RelapseGermany
-
CelgeneCompletedMultiple MyelomaUnited States
-
National Institutes of Health Clinical Center (CC)National Cancer Institute (NCI)CompletedLymphoma | Small Intestine Cancer | Unspecified Adult Solid Tumor, Protocol SpecificUnited States
-
M.D. Anderson Cancer CenterCompleted
-
National Cancer Institute (NCI)CompletedHigh Grade Glioma | Anaplastic Astrocytoma | Diffuse Intrinsic Pontine GliomaUnited States
-
Center for Primary Care and Public Health (Unisante)...Swiss Tropical & Public Health Institute; Ifakara Health Institute; University... and other collaboratorsRecruiting
-
CelgeneCompletedMyelodysplastic SyndromeUnited States, Germany
-
Celgene CorporationCompletedNewly Diagnosed Multiple MyelomaSpain, Netherlands, Austria, Australia, Italy, Russian Federation, United Kingdom, Israel, Belgium, Greece, Germany, Poland, Turkey, France, Denmark, Czech Republic, Belarus, Georgia, Ireland, Sweden, Switzerland, Ukraine
-
University Health Network, TorontoCelgene CorporationCompleted
-
Great Ormond Street Hospital for Children NHS Foundation...Newcastle-upon-Tyne Hospitals NHS TrustCompletedAllogeneic Haematopoietic Stem Cell TransplantationUnited Kingdom
-
Celgene CorporationPrologue Research InternationalCompletedMultiple MyelomaUnited States, Canada
-
M.D. Anderson Cancer CenterCelgene; Onyx Therapeutics, Inc.Terminated
-
CelgeneCompletedChronic Lymphocytic Leukemia | Leukemia, B-Cell, ChronicCanada, United States, Germany, Italy, Spain, Sweden, United Kingdom
-
CelgeneActive, not recruiting